Hereditary Hemorrhagic Telangiectasia synonyms

Hereditary Hemorrhagic Telangiectasia (HHT), also known as Osler-Weber-Rendu syndrome, is a rare genetic disorder characterized by abnormal blood vessel formations called telangiectasias and arteriovenous malformations. While historically referred to by the names of the physicians who described it, Hereditary Hemorrhagic Telangiectasia is the currently preferred clinical term used by medical professionals and international health organizations to ensure diagnostic clarity.

What are the common synonyms and historical names for Hereditary Hemorrhagic Telangiectasia?

In medical literature, you will frequently encounter the term Hereditary Hemorrhagic Telangiectasia alongside several eponyms. The most common synonym is Osler-Weber-Rendu syndrome, named after the three physicians—Sir William Osler, Frederick Parkes Weber, and Henri Jules Louis Marie Rendu—who provided definitive clinical descriptions of the disease in the late 19th and early 20th centuries. Other, less common terms that may appear in older clinical records include Rendu-Osler-Weber disease or simply HHT. Understanding these synonyms is vital for patients when reviewing older medical charts or performing literature searches, as the terminology has evolved significantly over the last century.

Why does Hereditary Hemorrhagic Telangiectasia have multiple names?

The presence of multiple names for Hereditary Hemorrhagic Telangiectasia is a direct result of historical medical reporting, where conditions were often named after the clinicians who first documented their specific features. As our understanding of the underlying genetics improved, the medical community shifted toward descriptive, pathologically accurate terminology. Today, Hereditary Hemorrhagic Telangiectasia is the standardized name because it accurately reflects the nature of the condition: it is inherited, it causes bleeding (hemorrhagic), and it involves small, dilated blood vessels (telangiectasia). This shift helps standardize care and improves communication between specialists like geneticists, hematologists, and interventional radiologists.

How is the condition classified in official medical systems?

Global health organizations use specific codes to categorize Hereditary Hemorrhagic Telangiectasia for diagnostic and billing purposes. These classifications ensure that data is tracked consistently across international borders. The following systems are the primary authorities for the diagnosis:

• Orphanet: Recognized as ORPHA:807.


• OMIM (Online Mendelian Inheritance in Man): Listed under entry #187300 (HHT1) and #600376 (HHT2).


• ICD-10-CM: Classified under code I78.0, which specifically denotes Hereditary Hemorrhagic Telangiectasia.


• NIH GARD: The Genetic and Rare Diseases Information Center uses the name Hereditary Hemorrhagic Telangiectasia as its primary entry.

Why is the term Hereditary Hemorrhagic Telangiectasia preferred today?

While the name Osler-Weber-Rendu syndrome remains a recognized eponym, modern medicine prioritizes Hereditary Hemorrhagic Telangiectasia because it is descriptive and internationally recognized. Using a descriptive name reduces confusion for patients and their families, especially those navigating the 141-member community on DiseaseMaps.org, where clear communication is essential for sharing experiences and treatment strategies. Standardized terminology also ensures that clinical trial databases and research registries remain cohesive, allowing for better tracking of the disease's progression and treatment efficacy.

Next steps

• Consult with a genetic counselor to discuss the inheritance patterns of Hereditary Hemorrhagic Telangiectasia within your family.


• Request a referral to an HHT Center of Excellence for specialized screening, such as bubble echocardiograms or MRIs.


• Connect with the DiseaseMaps.org community to share your journey and find support from others living with this condition.


• Ensure your primary care physician uses the ICD-10 code I78.0 to maintain consistent medical records.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• Orphanet: HHT (ORPHA:807) - https://www.orpha.net


• NIH Genetic and Rare Diseases Information Center (GARD): HHT - https://rarediseases.info.nih.gov


• OMIM: Online Mendelian Inheritance in Man - https://omim.org


• Cure HHT: Patient Foundation - https://curehht.org